Skip to content
LexBuild

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Special Protocol Assessment

---
identifier: "/us/fr/E7-12056"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Special Protocol Assessment"
title_number: 0
title_name: "Federal Register"
section_number: "E7-12056"
section_name: "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Special Protocol Assessment"
positive_law: false
currency: "2007-06-22"
last_updated: "2007-06-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E7-12056"
document_type: "notice"
publication_date: "2007-06-22"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "72 FR 34470"
fr_volume: 72
docket_ids:
  - "Docket No. 2000D-0084"
comments_close_date: "2007-07-23"
fr_action: "Notice."
---

#  Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Special Protocol Assessment

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

**DATES:**

Fax written comments on the collection of information by July 23, 2007.

**ADDRESSES:**

To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-6974. All comments should be identified with the OMB control number 0910-0470. Also include the FDA docket number found in brackets in the heading of this document.

**FOR FURTHER INFORMATION CONTACT:**

Elizabeth Berbakos, Office of the Chief Information Officer (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857,301-827-1482.

**SUPPLEMENTARY INFORMATION:**

In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

**Guidance for Industry on Special Protocol Assessment (OMB Control Number 0910-0470)—Extension**

In the *Federal Register* of July 31, 2006 (71 FR 43199), FDA published a 60-day notice requesting public comment on the information collection provisions. No comments were received.

| 21 CFR Section | No. of | Annual Frequency per Response | Total Annual | Hours per | Total Hours |
| --- | --- | --- | --- | --- | --- |
| Notification for Carcinogenicity Protocols | 21 | 2.19 | 46 | 8 | 368 |
| Requests for Special Protocol Assessment | 151 | 2.48 | 374 | 15 | 5,610 |
| Total |  |  |  |  | 5,978 |

Dated: June 15, 2007.

Jeffrey Shuren,

Assistant Commissioner for Policy.